HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

Spark Therapeutics, Inc.

1
Articles
Mentioned
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
0.95
Relevance Score

Coverage Timeline

April 2026
Roche’s $2.1 Billion Avacta Deal: Betting Big on Drug Delivery and Oncology Engineering Deals Mentioned
Apr 11, 2026
Roche has a mixed track record on that front, anyone remember the Spark Therapeutics gene therapy buyout?
Related Companies
Avacta Group plc
1 shared
Gilead Sciences, Inc.
1 shared
Novartis AG
1 shared
AstraZeneca PLC
1 shared
Merck & Co., Inc.
1 shared
Sanofi S.A.
1 shared
Roche Holding AG
1 shared
Pfizer Inc.
1 shared
AbbVie Inc.
1 shared